Combining SBRT With ICIs Does Not Improve PFS, OS in Solid Tumors
Adding stereotactic body radiation therapy to immune checkpoint inhibitor therapy was safe but failed to improve progression-free and overall survival.
Diagnosis & Disease Information
Preventing and Treating Malnutrition in Cancer Patients
Malnutrition may affect 30% to 85% of cancer patients, and it may account for 10% to 20% of deaths in these patients.
ChatGPT and the Future of Health Care
Experts describe how ChatGPT and other AI technologies will transform health care and research.
Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients.
RFS Should Not Be Surrogate for OS in Trials of Adjuvant Immunotherapy, Researchers Say
Relapse-free survival should not be used as a surrogate for overall survival in cancer trials testing adjuvant immunotherapy, according to researchers.
Clinical Pathway Regimens Cut Costs for Patients With Metastatic Solid Tumors
Clinical pathway treatment regimens are associated with significant cost savings for patients with metastatic solid tumors, a study suggests.
Drugmakers Are Abandoning Cheap Generics, and Now US Cancer Patients Can’t Get Meds
The main cause of the cancer drug shortage, experts agree, is the underlying weakness of the generic drug industry.
Older Patients Are Underrepresented in Trials Supporting Cancer Drug Approvals
Patients aged 65 years or older are underrepresented in clinical trials supporting cancer drug approvals, a study suggests.
ASCO 2023: Continued Success With Immunotherapy in Melanoma
At ASCO 2023, researchers reported positive results with nivolumab plus relatlimab, a cancer vaccine plus pembrolizumab, and pembrolizumab alone in patients with melanoma.
As Cancer Drug Shortages Increase, Patients’ Lives Are at Stake
Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...